# A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

> **NCT01396148** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** sunitinib malate dose escalation
- **DRUG:** sunitinib malate

## Key facts

- **NCT ID:** NCT01396148
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01396148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01396148, "A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01396148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*